Kevin Thornal is the current President and CEO of Nevro Corp, a company focused on medical devices. He joined the firm in April 2023 and also sits on the company's board of directors. With an M.B.A. from UC Berkeley, he...

Kevin Thornal is the current President and CEO of Nevro Corp, a company focused on medical devices. He joined the firm in April 2023 and also sits on the company's board of directors. With an M.B.A. from UC Berkeley, he has a strong background in the medical field. In 2023, his total compensation was over $11 million, with a significant amount coming from stock awards. One interesting aspect of his financial activity is his involvement in sizable insider trading. For instance, in June 2023, he reported insider sales valued at nearly $9.6 million. Kevin’s approach at Nevro focuses on enhancing the company’s strategies while aligning with performance metrics related to revenue and adjusted earnings. This focus keeps the company on track for growth in the medical device sector, especially in pain management solutions. His career is marked by substantial gains, reflecting his commitment to innovating in a space that significantly impacts patients' lives.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Neuro Corp CEOs

N

Kevin Thornal

CEO of Neuro Corp

Education

M.B.A. from the University of California, Berkeley

Sector of Economy

Healthcare

Born

January 1, 1973 - 52 years ago

CEO of Neuro Corp for

2 years 0 months (May 2023 - Present)

Previous Experience

Served as President at Nevro and held various leadership roles in the medical device industry.

Rivals

Competitors/colleagues of Kevin Thornal

Holdings

See how much did Kevin Thornal make over time.

Kevin Thornal's holdings are quite significant, reflecting his confidence in Nevro Corp. As of 2023, he has executed several insider trades, indicating active management of his equity. Notably, his largest trade was in April 2023, where he sold shares for...

Kevin Thornal's holdings are quite significant, reflecting his confidence in Nevro Corp. As of 2023, he has executed several insider trades, indicating active management of his equity. Notably, his largest trade was in April 2023, where he sold shares for approximately $9.6 million. Over the past few years, his trades have ranged significantly, with values fluctuating from as little as $650K to highs exceeding $9 million monthly. This consistent trading suggests that Mr. Thornal closely monitors the market and adapts his strategy accordingly, potentially capitalizing on the performance of Nevro’s stock. As of now, a considerable portion of his wealth is tied up in stocks, which aligns his interest directly with the health of the company.

Mar 18, 2025

H

shares

HOLX @ $61.98

Total Stock Sold

$3.43M

HOLX

$3.43M

49,875 HOLX shares

What if they kept their stock?

If Kevin Thornal didn't sell their stock, today they would have:
Extra HOLX49,875 shares worth $2.61M.
This is -24.01% and $824.40K less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Kevin Thornal.

HOLX

$1.44M

HOLX at $75.34/share

Nov 15, 2022

Sale

HOLX

6,724 shares

HOLX

Nov 7, 2022

Received

HOLX

12,277 shares

HOLX

Nov 1, 2022

Received

HOLX

6,150 shares

HOLX

Nov 8, 2021

Received

HOLX

28,764 shares

HOLX

Nov 1, 2021

Received

HOLX

$1.25M

HOLX at $73.99/share

Dec 10, 2020

Sale

HOLX

5,120 shares

HOLX

Nov 9, 2020

Received

HOLX

17,750 shares

HOLX

Nov 2, 2020

Received

HOLX

$715.43K

HOLX at $51.51/share

May 15, 2020

Sale

HOLX

5,481 shares

HOLX

Nov 11, 2019

Received

Compensation History

See how much did Kevin Thornal make over time.

In 2023, Kevin Thornal’s total compensation reached $11.45 million, a mix of salary, bonuses, and stock awards. His base salary was $515,625, but he also received a bonus of $402,750, reflecting the company's performance. The stock awards were the largest portion of his pay, valued at over $10 million, compensating grants made at his hiring, vesting over time. His total compensation package also included a sign-on bonus of $250K and other benefits worth around $455K, showcasing the company's strategy to attract top talent in the competitive medical device sector. This level of compensation is indicative of the responsibilities he holds at Nevro, reinforcing the link between executive pay and company performance.

Year

2023

Total Compensation

$4.53M

Salary

$750.00K

Board Justification

The compensation philosophy aims to attract, motivate, and reward leaders with the skills necessary to execute the strategic plan and maximize stockholder value, aligning compensation with performance and market benchmarks.

Bonus

$402.75K

Board Justification

Achievement under the 2023 corporate bonus plan resulted in a payout to our NEOs of 53.7% of their target bonus opportunity.

Other

$455.00K

Board Justification

Includes a sign-on bonus of $250,000, a moving allowance of $200,000, and $5,000 in matching contributions under the 401(k) Plan.

Restricted Stock

$2.92M(135.62K RSU)

Board Justification

The RSUs granted to Mr. Thornal upon hiring, vesting in three equal installments on the anniversary of the grant date, subject to continued service.

Performance Metrics

The performance metrics for 2023 included revenue and adjusted EBITDA, each weighted 50%.

Other Neuro Corp CEOs

Here are other CEOs of Neuro Corp

D. Keith Grossman

Ex-CEO of Neuro Corp

March 2019 - January 2023